top of page
Search

FDA Clearance of IND Application for TACC3 PPI Inhibitor A2A-252 in Women's Cancer

  • Writer: A2A Pharma
    A2A Pharma
  • May 22, 2023
  • 0 min read


 
 
 

Recent Posts

See All
A2A Appoints New Advisors

Dr. Siddhartha Mukherjee, Dr. Annalisa Jenkins and Dr. Srikumar Chellappan join A2A’s Advisory Board. LEARN MORE

 
 
 

Comments


bottom of page